Jazz Pharmaceuticals to open a new production facility for cannabis-based medications

- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

             London, United Kingdom (CU)_ Jazz Pharmaceuticals has revealed the opening of its new advanced manufacturing facility at Sittingbourne’s Kent Science Park (KSP). The facility will be used to produce cannabis-based medications that have been licensed by regulatory authorities. Jazz Pharmaceuticals and its branch GW Pharmaceuticals have planned the facility with environmental regulation in mind and have said that this will continue throughout the plant’s construction and operation. This will involve the construction of…

Hot this week

Cyprus to Invest $3.9 Billion in Public Infrastructure Over the Next Three Years

Cyprus is gearing up to spend some €3.5 billion...

US Resident Arrested Over Deadly British Columbia School Shooting

A 30-year-old man from Washington state has been arrested...

Kenya Confirms First Ebola Case as Bundibugyo Virus Outbreak Spreads Across East Africa

On October 5th, 2026, authorities discovered the lifeless body...

Kuwait Cuts Sulphur Prices—But What Is the Global Market Trying to Tell Us?

KUWAIT CITY (Kuwait) — October 6, 2026 – The...

Chinese EVs Are Winning Britain’s Roads—Will London Make Them Pay More?

October 6, 2026, LONDON, UK — The rapid arrival...
- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories